̽��ֱ��

For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and...

Transmissible cancers are incredibly rare in nature, yet have arisen in Tasmanian devils on at least two separate occasions. New research from the...

Gifts totalling more than £32 million, together with government funds of over £17 million, have enabled the launch of a highly innovative Centre in...

Nanobots that patrol our bodies, killer immune cells hunting and destroying cancer cells, biological scissors that cut out defective genes: these are...

When a drug fails late on in clinical trials it’s a major setback for launching new medicines. It can cost millions, even billions, of research and...

Researchers are working with pharmaceutical companies to make improvements across the whole supply chain, from how a pill is made to the moment it is...

An ambitious seminar series began last week with a discussion of a remarkable documentary. Filmed in a pioneering hospice, ̽��ֱ��Time to Die addresses...

Researchers have identified the cause of chronic, and currently untreatable, pain in those with amputations and severe nerve damage, as well as a...